Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Myriad Genetics and Roche to collaborate on cardiovascular drug discovery

Jan. 13, 2000

Almirall Prodesfarma presents new PDE5 inhibitor series

Jan. 12, 2000

Priority review granted to antihypertensive drug Vanlev

Jan. 11, 2000

Human Genome Sciences discloses novel growth-regulatory protein, its production and use

Jan. 11, 2000

PR39 induces therapeutic angiogenesis in preclinical models

Jan. 10, 2000

New series of NOS inhibitors in early development at Pfizer

Jan. 6, 2000

CV Therapeutics establishes Tangier drug discovery program

Jan. 5, 2000

Calcineurin inhibitor FK-506 prevents cardiac hypertrophy in rats

Jan. 4, 2000

NEP inhibition with candoxatrilat increases renal response in mild CHF

Jan. 4, 2000

Nonpeptide endothelin antagonists from Warner-Lambert selective for ETA receptors

Jan. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...